Prescription Drugs, Lower Taxes, Power J&j 3q Beat

A jump in prescription drug sales and a sharply reduced tax bill boosted Johnson & Johnson's third-quarter sales and profit, which beat Wall Street expectations. The world's biggest maker of health care products on Tuesday also slightly raised its profit forecast for the year. The New Brunswick, N.J., maker of baby products, biotech drugs and medical devices reported net income of $3.93 billion, or $1.44 per share.Read more on NewsOK.com

Topics:  johnson   wall street   the new brunswick   n.j   newsok   johnson   prescription   drugs   beat   maker   products   profit   sales   
BING NEWS:
  • Judge rejects J&J, BMS challenges to Medicare drug pricing program
    Selling to Medicare is a choice plaintiffs can accept or not accept," wrote Judge Zahid Quraishi. "[It] may be less profitable than it was before the institution of the program, but that does not make ...
    05/1/2024 - 6:18 am | View Link
  • More

 

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News